EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The impact of SETBP1 mutations in neurological diseases and cancer

Naoki Kohyanagi, Takashi Ohama iD

Genes to Cells · 2023

DOI: 10.1111/gtc.13057 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes to Cells, 2023. Verfasst von Naoki Kohyanagi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan. Hauptthemen laut MEDLINE: Intellectual Disability, Abnormalities, Multiple, Craniofacial Abnormalities, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SE translocation (SET) is a cancer‐promoting factor whose expression is upregulated in many cancers. High SET expression positively correlates with a poor cancer prognosis. SETBP1 (SET‐binding protein 1/SEB/MRD29), identified as SET‐binding protein, is the causative gene of Schinzel–Giedion syndrome, which is characterized by severe intellectual disability and a distorted facial appearance. Mutations in these genetic regions are also observed in some blood cancers, such as myelodysplastic syndromes, and are associated with a poor prognosis. However, the physiological role of SETBP1 and the molecular mechanisms by which the mutations lead to disease progression have not yet been fully elucidated. In this review, we will describe the current epidemiological data on SETBP1 mutations and shed light on the current knowledge about the SET‐dependent and ‐independent functions of SETBP1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intellectual DisabilityAbnormalities, MultipleCraniofacial AbnormalitiesNeoplasmsHumansMutationCarrier ProteinsNuclear Proteins

Stichwörter der Autor:innen

PP2ASETSETBP1cancerneurological disease

Substanzen

SETBP1 protein, humanCarrier ProteinsNuclear Proteins

Autor:innen und Institutionen

  • Laboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.

ORCID-Profile: Takashi Ohama

Förderung

  • JSPS KAKENHI

Zitieren

APA

Kohyanagi, N., & Ohama, T. (2023). The impact of SETBP1 mutations in neurological diseases and cancer. Genes to Cells. https://doi.org/10.1111/gtc.13057

Vancouver

Kohyanagi N, Ohama T. The impact of SETBP1 mutations in neurological diseases and cancer. Genes to Cells. 2023. doi:10.1111/gtc.13057

BibTeX
@article{Kohyanagi2023,
  author = {Kohyanagi, Naoki and Ohama, Takashi},
  title = {The impact of SETBP1 mutations in neurological diseases and cancer},
  journal = {Genes to Cells},
  year = {2023},
  doi = {10.1111/gtc.13057}
}
Kostenlos starten →